Nicotine De-addiction Product Sales Grow at over 10% in 2018, US Remains the Largest Market
Nicotine de-addiction product sales are likely to grow at a steady pace, as quit smoking and smoking cessation gain momentum. E-cigarettes are increasingly losing favor, owing to lack of empirical support from researchers on their effectiveness. Vaping, on the other hand, is gaining popularity, even though it is yet to be officially categorized as a nicotine de-addiction or smoking cessation technique. These insights are according to a new research by Fact.MR, which tracks historical data and future projections.
According to the study, demand for nicotine deaddiction products is likely to grow at 12% y-o-y in 2018. The gains in nicotine de-addiction product sales are on account of a combination of factors, including growing health and awareness trend.
Request 100 Page Sample Report Now: https://www.factmr.com/connectus/sample?flag=S&rep_id=2372
Although smokers are unanimous in acknowledging the risk they put themselves and those around them, the awareness has not translated into quitting smoking altogether. Although smoking is becoming less popular in a number of countries, the total number of smokers is still over a billion – or roughly 1 in 6 people. Smoking continues to be a major healthcare concern, not only for smokers, but also for those inhale the smoke.
According to the report, demand for nicotine and smoking cessation products is likely to remain lower in developing countries vis-à-vis developed countries. The study found that willingness to spend on nicotine de-addiction and smoking cessation products was higher in developed countries as compared to developing countries.
Speak with an Analyst to learn more (methodology) @ https://www.factmr.com/connectus/sample?flag=RM&rep_id=2372
The report finds that regulations on nicotine de-addiction and smoking cessation products remain a key influencing factors in the market. In North America, Family Smoking Prevention and Tobacco Control Act (US) and Tobacco and Vaping Products Act (TVPA) regulated the sales of vaping and e-cigarettes. These guidelines regulate various aspects of smoking cessation and nicotine de-addiction products – from manufacturing to distribution.
The report finds that growth of nicotine de-addiction products market will also be positively influenced by growing focus on enacting smoke-free air laws. Bans pertaining to smoking in public places are also influencing sales of nicotine deaddiction products market.
Although the outlook on nicotine deaddiction products market remains positive, concerns about side-effects associated with the use of these products continue to stymie growth. Further, their effectiveness in reducing or quitting smoking altogether has been ambiguous, leading to lack of confidence among smokers. Reported incidents of diarrhea, skin & eye irritation, and behavior changes are among the key challenges for their widespread adoption.
Speak To Research Analyst For Detailed Insights: https://www.factmr.com/report/2372/smoking-cessation-products-market
The research study also tracks the competitive landscape of the nicotine deaddiction products market. The recent developments, as well as business and product strategy of key players is mentioned in the research study. Some of the leading players profiled in the research study include Johnson & Johnson Inc., Pfizer, Inc, GlaxoSmithKline plc, Imperial tobacco ltd., Perrigo Company plc, ITC Limited, Cipla Ltd., Fertin Pharma, Reynolds American Inc., and Alkalon A/S.
According to the report, the US and EU5 will continue to account for the maximum sales of nicotine de-addiction products. Sales in these markets will be pushed by a combination of growing health and wellness awareness, combined with government initiatives on reducing the menace of smoking.
Gains are also likely to be significant in Asia Pacific, however, average spend on nicotine deaddiction products in APAC countries is likely to be significantly lesser than North America and Europe. Sensing the emerging opportunities in APAC, global manufacturers are focusing on strengthening their presence. Further, local players in APAC are catering to the domestic demand, with cost-effective offerings. Although APAC currently is a less attractive market as compared to North America and EU5, it is likely to grow at a health rate in the future.
Get Access to Report @ https://www.factmr.com/checkout/2372/S
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.
11140 Rockville Pike
Rockville, MD 20852
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nicotine De-addiction Product Sales Grow at over 10% in 2018, US Remains the Largest Market here
News-ID: 1482577 • Views: 125
More Releases from Fact.MR
PCR and Real-time PCR Molecular Diagnostics Market to Surpass US$ 6 Bn by 2030, …
As per data from the World Health Organization, millions of deaths can be attributed to diseases such as cancer and HIV each year. Further, the recent outbreak of the COVID-19 virus has also created massive demand for effective diagnostics processes. The PCR and real-time PCR molecular diagnostics market has been gaining traction in recent years on the back of investments by PCR diagnostic test manufacturers towards the incorporation of molecular
Biobanking Market to Soar to US$ 3.5 Bn by 2027, Notes Fact.MR
Biobanks are a type of repository which is used in the storage of biological samples, including human and animal tissues, which primarily find use in research applications. Consequently, the process of biobanking has become a very important part of medical research and has played a major role in modern science fields such as personalized medications, and genomics. The global biobanking market is expected to grow at a healthy CAGR of ~
Mini LED Market to Expand 7.5X by 2030, Finds New Study by Fact.MR
In recent years, increasing popularity of OLED TVs in China and India has been significantly influencing growth of the mini LED market. With an increase in disposable income of a majority of the population in these countries, the inclination towards smart screens with higher lifespan and better performance is expected to open up numerous growth opportunities for the mini LED market. Moreover, aspiring and affluent households have increased their spending
Uncertainty Surrounding COVID-19 to Shave-off Growth in Electrical Steel Market …
The global electrical steel market has utilized the opportunities in the market over the last decade with sales of electrical steel pegged at US$ 20.4 Bn in 2019. However, sales are set to plummet during in the middle two quarters of 2020 owing to COVID-19. In addition, several automakers have shuttered their production units, causing incalculable loss to the electrical steel market in 2020. However, the demand of electrical steel
More Releases for Nicotine
Synthetic Nicotine Market to Witness Robust Expansion by 2025
LP INFORMATION recently released a research report on the Synthetic Nicotine market analysis, which studies the Synthetic Nicotine's industry coverage, current market competitive status, and market outlook and forecast by 2025. Global “Synthetic Nicotine Market 2020-2025” Research Report categorizes the global Synthetic Nicotine market by key players, product type, applications and regions,etc. The report also covers the latest industry data, key players analysis, market share, growth
Nicotine Gums and Lozenges Market: Competitive Dynamics & Global Outlook 2025
LP INFORMATION recently released a research report on the Nicotine Gums and Lozenges market analysis, which studies the Nicotine Gums and Lozenges's industry coverage, current market competitive status, and market outlook and forecast by 2025. Global "Nicotine Gums and Lozenges Market 2020-2025" Research Report categorizes the global Nicotine Gums and Lozenges market by key players, product type, applications and regions,etc. The report also covers the latest
Global Nicotine Market Research Report
This report studies the global Nicotine market status and forecast, categorizes the global Nicotine market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Alchem International Siegfried CAMBREX CHARLES CITY FERTIN PHARMA JOHNSON AND JOHNSON CONSUMER INC Laboratorios Haymann Mallinckrodt Pharmaceuticals PORTON FINE
Global Nicotine Polacrilex Market Research Report
This report studies the global Nicotine Polacrilex market status and forecast, categorizes the global Nicotine Polacrilex market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report BGP HEALTHCARE Cambrex Corporate Nicobrand Alchem International DIXIE CHEMICAL FERTIN PHARMA Laboratorios Haymann MALLINCKRODT NICOBRAND PORTON FINE
Global Nicotine Gum Market Study 2015-2025, by Segment (2 mg nicotine gum, 4 mg …
Global Nicotine gum is a smoking cessation product that helps smokers to slowly overcome nicotine addiction. Nicotine is released by chewing the gum and is absorbed into the blood stream through the lining of the mouth, which helps smokers to slowly reduce their craving for nicotine. It is one of nicotine replacement therapies (NRT's) and it is an over-the-counter medication. View TOC for Research Report @ https://www.researchgoal.com/reports/99SHea20181802175 The global Nicotine Gum market
Nicotine Addiction - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Nicotine Addiction - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nicotine Addiction - Pipeline Review, H2 2017, provides an overview of the Nicotine Addiction (Central Nervous System) pipeline landscape. Nicotine addiction also called tobacco dependence is an addiction to tobacco products caused by the drug nicotine.